Connect with us


Why Should Hospitals Use A Health Monitoring System?



The recent pandemic showed that the global health care industry was not ready for such a dramatic influx of patients with a previously unknown virus. In response to the coronavirus outbreak, new technologies designed to optimize the work of doctors and save more lives of those infected have begun to appear. The health monitoring system is already a fairly adapted practice. However, it is a must-have in modern conditions.

Health Monitoring System Definition

Health Monitoring System (HMS) is a smart and multi-layer solution that enables health data transfer from a patient’s wearable device to the doctor’s mobile application. This innovation is useful and beneficial for doctors, hospital owners, and patients, as it allows the provision of data-driven medical care in the smartest way possible.

Health Monitoring System is a must-have for providing quality medical services, quick response to changing epidemiological situations, and improved safety for both patients and doctors. And this is not the only reason to develop an HMS for your hospital in the current conditions.

Main Reasons To Use HMS For Hospitals

Here are the main reasons why a health monitoring system is a must-have solution for hospitals in unpredictable 2020 and beyond.

Provide Innovative Healthcare Services

The Health Monitoring System is the modern answer to outdated ways of managing, controlling, and monitoring patients. Of course, the ability to provide medical care using innovation and receive data-driven health services makes doctors work more efficient, reducing the likelihood of medical error, and patient’s anxiety as a result.

What is more, cloud computing, 5G, artificial intelligence, natural language processing technologies, and the Internet of Medical Things can make healthcare delivery even more advanced, plus match the healthcare services with patient’s preferences, according to Deloitte’s research.

Prioritize Patients In A Smarter Way

The Health Monitoring System allows physicians to smartly prioritize patients, saving more lives than it would be possible without the use of innovative technology. By relying on patient data from wearable devices, doctors can make more informed decisions whether to continue treatment in the hospital or about the patient’s ability to continue treatment at home, independently but under constant remote supervision.

Thus, the hospital can manage free beds without the risk of complications for patients who are released for home treatment and use the vacated beds for patients in critical conditions.

Monitor Chronic Patients Remotely

Chronic diseases are incurable, but such patients have every chance to live a quality life if their health condition is under their personal control and under the supervision of the attending physician. What is more, in most cases, chronic patients require hospitalization only when their diseases enter the critical phase. During the remission period, they can stay at home, taking the necessary medications, and leading the prescribed lifestyle.

A wearable device connected to the Health Monitoring System allows the attending physician to monitor chronic patients remotely, from time to time reviewing the treatment plan and responding promptly to critical situations.

Furthermore, AI-powered health monitoring systems are able to catch unnoticed changes in health conditions and alarm the doctor and the patient on the necessity to respond and prevent a critical condition.

Use the Available Resources Wisely And Save Money

By using wearable patient devices connected to a health monitoring system, doctors can rely on the transmitted data almost entirely. This eliminates the need to measure blood pressure, heart rate, blood sugar, and other indicators manually, thereby freeing up time, resources, and effort for patients in need of emergency care.

A system powered by artificial intelligence can give doctors even stronger information support about the health of patients by analyzing the whole medical history, taking into account the current indicators, and making reasonable assumptions about the methods of treatment the patient needs based on this data. Even though these assumptions will still need to be checked and approved by the attending physician, the likelihood of medical error is significantly reduced.


There is no doubt that over the next few years, a health monitoring system for hospitals will become as traditional a way of managing patients as the paper files used in the past. What is more, the coronavirus pandemic has become a real challenge for both private and public hospitals around the globe. The integration of a health monitoring system into the healthcare delivery process is the first step towards innovative, low-risks, and safe medical services.

Continue Reading
Click to comment
Notify of
Inline Feedbacks
View all comments


A New way around Drug Resistant Tuberculosis




Researchers at Purdue University have created a powerful compound that specifically tackles Tuberculosis, a leading killer worldwide.

The scientists came up with a series of inhibitors that destroy TB by targeting a protein necessary for the survival of the TB molecule.

Tuberculosis destabilizes the immunity of patients with the help of Protein Tyrosine Phosphates B (mPTPB). Their findings were published in the Journal of Medicinal Chemistry.

“The death toll from TB is particularly high because of drug-resistant strains,” said Zhong-Yin Zhang, distinguished professor and head of Purdue’s Department of Medicinal Chemistry and Molecular Pharmacology and director of Purdue Institute for Drug Discovery. “These inhibitors are part of a promising new approach to developing TB therapeutic agents with novel targets and mechanisms of action to help save more lives.”

Right now, doctors rely on antibiotic preparations to treat Tuberculosis. The problem is that many patients don’t complete their dose of antibiotics and this non-adherence leads to the development of drug resistant tuberculosis.

“We developed a platform to target mPTPB for novel anti-TB agents that builds on technologies we pioneered to modulate abnormal protein tyrosine phosphatase activity for the treatment of diseases such as cancer, diabetes and autoimmune disorders,” Zhang elaborated.

According to Zhang, the inhibitors’ have unique properties that make them incredibly useful. They have a lighter molecular weight and superior metabolic stability. They give scientists an excellent opportunity to create better treatments for Tuberculosis.

The visionary scientists are already working to patent the exciting new technology. The hunt is on for partners who will work with Purdue to further the development of the new technology. This is together with the Purdue Research Foundation Office of Technology Commercialization.

Continue Reading


A New Era Diagnosing Parkinson’s




Scientists are on the verge of introducing a cheaper, faster, and completely painless test for Parkinson’s.

The researchers based at the University of Manchester said the new test which is already in sight, will herald a new era in diagnosing Parkinson’s disease.

A research paper published in the journal Nature Communications details the researchers’ findings that demonstrate hope in a new way of diagnosing Parkinson’s that is simple and painless – a skin swab.

The test examines compounds in the skin’s natural oil called sebum which is not the same in people who have Parkinson’s.  Sebum is a protective oily layer on human skin.

“We believe that our results are an extremely encouraging step towards tests that could be used to help diagnose and monitor Parkinson’s,” explained University of Manchester Prof Perdita Barran.

“Not only is the test quick, simple and painless but it should also be extremely cost-effective because it uses existing technology that is already widely available.

“We are now looking to take our findings forwards to refine the test to improve accuracy even further and to take steps towards making this a test that can be used in the NHS and to develop more precise diagnostics and better treatment for this debilitating condition.”

The team worked with 500 sebum samples. All of them were extracted from people’s upper backs. Some of the subjects had Parkinson’s and some did not.

The scientists used mass spectrometry to isolate 10 chemical compounds that become reduced or elevated when the person has Parkinson’s.

They could diagnose people with Parkinson’s with an accuracy of 85%.

Because Parkinson’s takes so long to progress, it can take years for people to visit a doctor because the symptoms don’t become noticeable for years.

Specialists use a DaTscan to see whether the brain is losing dopamine-producing brain cells. This means that a patient is developing Parkinson’s disease.

The trouble is that there are other, more rare neurological conditions that cause the same loss of dopamine-producing brain cells. This makes the Parkinson’s diagnoses more complicated.

Around a quarter of people living with Parkinson’s in the UK were misdiagnosed with something else first, according to a survey of more than 2,000 people living with Parkinson’s in the UK.

56-year-old Daxa Kalayci is a Leicester native who has known that she was living with Parkinson’s since her diagnosis in September 2019. In the four years before that that, Kalayci had been misdiagnosed several times over.

“This test could be a game-changer for people living with Parkinson’s and searching for answers, like I was,” she quipped.

“I am so happy with this news because it will mean that in future people won’t have to experience the anxiety of multiple appointments, long waiting times and sleepless nights.

“The sooner this test is available, the better. Anything that can help people looking for a diagnosis is a bonus.”

Continue Reading


Scientists will Soon spot Diseases and find exoplanets with super Tiny photonic devices




Researchers working in Sweden have created a microcomb capable of detecting diseases faster and making optical communications systems more efficient, among other exciting applications.

The scientists at the Chalmers University of Technology in Sweden have built the photonic device (microcomb) with the capability to produce optical frequencies on a micro resonator – a minute optical cavity.

Effectively, the microcomb is like a ruler of light that measures frequencies with extreme accuracy.

The microcomb generates an array of optical frequencies whose colors are evenly distributed, making it more or less a ruler of light that measures and produces frequencies with extreme accuracy.

The researchers used a chip to develop a new microcomb based on two micro resonators instead of one. The interaction between the two micro resonators is similar to atoms that bind together to create a diatomic molecule known as a photonic molecule.

The microcomb is a device that is readable and capable of being tuned as well as being replicated into something multiple times more efficient than the best devices available at the moment.

The results are extremely significant. “The reason why the results are important is that they represent a unique combination of characteristics, in terms of efficiency, low-power operation and control, that are unprecedented in the field,” explained PhD candidate Óskar Bjarki Helgason.

This is by no means the first time that scientists have created a microcomb on a chip, but it is definitely the first time that scientists have deployed a second micro resonator to beat many of the limitations that have never been surmounted before.

The arrangement has created a number of unique characteristics. The microcomb is so small that it can sit on the tip of a human hair and leaves relatively wide gaps between its teeth.

These wide teeth mean that engineers and researchers have massive opportunities to explore the possibilities.

The microcomb is capable of making optical communication systems vastly more efficient by replacing many lasers with a single microcomb placed in data centers.

The microcombs have great potential for use in lidar to power self-driving vehicles where they can be deployed to record distances, or to calibrate spectrographs deployed in astronomical observations.

Microcombs are also ideal for making optical clocks more accurate as well as improving health monitoring apps in mobile phones, and increasing the accuracy of diagnostic tests that rely on analyzing exhaled air.

“For the technology to be practical and find its use outside the lab, we need to co-integrate additional elements with the micro resonators, such as lasers, modulators, and control electronics,” explained Dr Victor Torres-Company, who is in charge of the Ultrafast Photonics Laboratory at Chalmers University. “This is a huge challenge, that requires maybe five to 10 years and an investment in engineering research, but I am convinced that it will happen.

“The most interesting advances and applications are the ones that we have not even conceived of yet. This will likely be enabled by the possibility of having multiple microcombs on the same chip. What could we achieve with tens of microcombs that we cannot do with one?”

Continue Reading